and again... any basic internet search can provide insight into the treatment cost / delivery structure of the business model in precincts where it currently operates Norway 'The current MDMA treatment protocols involve about 42 hours of treatment, and there are two therapists on site at any one time. This includestwo to three eight-hour MDMA sessions and twelve 90-minute psychotherapy sessions for preparation and integration. The estimate for the entire treatment is around USD 15,000. I would like to emphasize that this is not a treatment available today anywhere legally and not outside clinical trials as of today.'
it soon will be in Melbourne / Australia with significant revenues and health outcomes as a result
I don't know how many treatment suites will be in the newly leased premises in Melbourne but if we assume there will be 10 and at peak operational capacity there will be perhaps 6 to 7 in use at any point in time and each completing 2 x 8hr 'treatment' sessions across the hours of operation daily...that is a significant business model in an emerging drug therapy.
Would also indicate why after hours operational capacity is a huge asset - duration of treatment sessions demand extended hours of operation and add to the viability of the revenue model while ensuring quality service delivery for significantly improved quality of life outcomes.
simple back of the envelope numbers based on that Melbourne operation and the included modelled logistics indicate that single initial leased set of suites will be conservatively a many multiple million dollar operation annually.
and that is one of many to be establish nationally and rolled out globally ....do your own sums - its pretty simple to see what lies ahead
Treatment rebates ? - can bet your mother the company will be engaging with the insurance sector to set the framework... its already happening in the sector as an employee related benefit program .....advantage Incannex !